ArticleCancers2018

Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.

Antoni Xavier Torres-Collado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.